← Back to listWill the first approved psychedelic become a blockbuster?BioPharma DiveMeagan ParrishNovember 20, 2026Compass and Usona are vying for an FDA first, but pricing, payer coverage and patient access could determine the commercial winner.Read original article← Back to list